Michelle benefiel dating
Invited participant, "Evaluation and Therapy of Recurrent Thrombosis: The Hypercoagulability Syndromes." (g) American Society of Clinical Pathologists Workshop, New Orleans 1991.
Workshop Director, "An Approach to the Laboratory Evaluation of Inherited Thrombotic Disorders." (h) Symposium on Medical, Surgical and Radiologic Aspects of Treating Acute and Chronic Vascular Occlusive Disease, Salt Lake City, Utah, 1992.
He has published over 170 journal articles and book chapters as well as 2 books, primarily on coagulation subjects. ATLAST Enoxaparin Stent Study, Member, Data Safety Monitoring Board, 1996-1998.
degrees from Tulane University, did internal medicine training at Baylor College of Medicine, and received hematology fellowship training at UCSF. Rodgers' clinical and research interests include benign hematology, especially disorders of hemostasis and thrombosis. ARG 911: An open-label study of Novastan® (argatroban) in patients with heparin-induced thrombocytopenia or heparin-induced thrombocytopenia and thrombosis syndrome, 1996.
Workshop Director, Coagulation-Chemistry Interactions in the New Laboratory Environment: An Introduction to Coagulation Testing and Standardization.
(r) Utah Society for Clinical Laboratory Science/Clinical Laboratory Management Association. Invited participant, "Laboratory Evaluation of Hypercoagulability." (s) American Association for Clinical Chemistry Workshop, Chicago 1998.
ADMINISTRATIVE EXPERIENCE: Intramural Gladstone Foundation Laboratories for Cardiovascular Disease, July 1984 - June 1987 Biosafety Committee Director, Blood Donor Screening Program University Academic Senate Representative, University of Utah, 1990 - 1993 Member, VA Research and Development Committee, 1991-1994 Member, Division of Hematology-Oncology Fellowship Training Committee, 1991 - present Member, Pharmacy and Therapeutics Adverse Drug Reaction Subcommittee, 1993 - present Member, Committee to develop practice guidelines for outpatient treatment of DVT with low molecular weight heparin, 1998 Member, Second Year Curriculum Committee, 1998 - present Member, Second Year Promotions Committee, 1998 - present Course Director, Hematology Organ Systems Course, 1998 - 2009 Course Director, Hematology Section, MSI Curriculum, 2010 - present Member, Medical School Admissions Committee, 1999 - 2004 Member, Laboratory Evaluation and Guideline Committee, 1999 - present Chair, University Hospital Anticoagulation Committee, 2000 Member, Institutional Review Board, University of Utah Health Sciences Center, 2004 - 2007 Member, Tenure Advisory Committee, Department of Internal Medicine, 2004 - present Member, University of Utah Technology Review Board, 2007 - Present Member, Tenure Faculty Review/Clinical Faculty Review Committee, Department of Internal Medicine, 2007 - present Member, Intermountain Healthcare Anticoagulation Task Force, 2007 - 2009 Member, University of Utah Anticoagulation Safety Committee, 2009 - present Extramural Western Section Councilor for Utah, American Federation for Clinical Research, 1990 - 1995 Member, Council on Hematology, American Society of Clinical Pathologists, 1999 - 2001 Member, Hematology Resource Council, American Society of Clinical Pathologists, 2002 - present American Society of Hematology 1978 American Federation for Clinical Research 1980 American Heart Association 1981 Council on Thrombosis - 1981 Fellow - 1997 Western Society for Clinical Investigation 1987 International Society of Thrombosis and Haemostasis 1987 Western Association of Physicians - 1993 American Society of Clinical Pathologists - 1994 Academy of Clinical Laboratory Physicians and Scientists - 1997 North American Specialized Coagulation Laboratory Association - 1997 Chair, Subcommittee on Factor Proficiency Testing - 2005? CERTIFICATION EXAMINATIONS: FLEX June 1976 National Boards Part I June 1972 Part II September, 1975 Part III December, 1976 Diplomate, American Board of Internal Medicine September, 1979 (#69461) Diplomate, American Board of Internal Medicine, Subspecialty of Hematology - November, 1982 (#69461) Diplomate, American Board of Pathology (Hematology) May, 1984 State Licensure Louisiana (1976 1987) California (1978-2002) Utah (since 1988) VIII. George, William J., Briggs, Daniel W., Rodgers, George M., and Fisher, James W.: Metabolism of Erythropoietin.
Workshop Director, "An Approach to the Laboratory Evaluation of Inherited Thrombotic Disorders, and Practical Aspects of Monitoring Anticoagulation." (l) Symposium on New Developments in the Management of Common Vascular Diseases, Park City, Utah, 1995.
RESEARCH INTERESTS: (a) Physiological regulation of hemostasis (b) Procoagulant activities of vascular endothelium (c) Role of coagulation in arteriosclerosis (d) Antithrombotic therapy X.